Psychiatric symptoms of noradrenergic dysfunction: A pathophysiological view
What psychiatric symptoms are caused by central noradrenergic dysfunction? The hypothesis considered in this review is that noradrenergic dysfunction causes the abnormalities in arousal level observed in functional psychoses. In this review, the psychiatric symptoms of noradrenergic dysfunction were...
Gespeichert in:
Veröffentlicht in: | Psychiatry and clinical neurosciences 2014-01, Vol.68 (1), p.1-20 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 20 |
---|---|
container_issue | 1 |
container_start_page | 1 |
container_title | Psychiatry and clinical neurosciences |
container_volume | 68 |
creator | Yamamoto, Ken‐ichi Shinba, Toshikazu Yoshii, Mitsunobu |
description | What psychiatric symptoms are caused by central noradrenergic dysfunction? The hypothesis considered in this review is that noradrenergic dysfunction causes the abnormalities in arousal level observed in functional psychoses. In this review, the psychiatric symptoms of noradrenergic dysfunction were inferred pathophysiologically from the neuroscience literature. This inference was examined based on the literature on the biology of psychiatric disorders and psychotropics. Additionally, hypotheses were generated as to the cause of the noradrenergic dysfunction. The central noradrenaline system, like the peripheral system, mediates the alarm reaction during stress. Overactivity of the system increases the arousal level and amplifies the emotional reaction to stress, which could manifest as a cluster of symptoms, such as insomnia, anxiety, irritability, emotional instability and exaggerated fear or aggressiveness (hyperarousal symptoms). Underactivity of the system lowers the arousal level and attenuates the alarm reaction, which could result in hypersomnia and insensitivity to stress (hypoarousal symptoms). Clinical data support the hypothesis that, in functional psychoses, the noradrenergic dysfunction is in fact associated with the arousal symptoms described above. The anti‐noradrenergic action of anxiolytics and antipsychotics can explain their sedative effects on the hyperarousal symptoms of these disorders. The results of animal experiments suggest that excessive stress can be a cause of long‐term noradrenergic dysfunction. |
doi_str_mv | 10.1111/pcn.12126 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1492623276</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1490708266</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5116-662d55356a3866cc59d42ffd99285a5a7280ddc3a7c17517d6bb04349665138d3</originalsourceid><addsrcrecordid>eNqN0U9LwzAYBvAgipvTg19ACl700C1v0qSttzH8B0N30HPJktR1tE1NWke_vZmbHgTBXBJ4fzwkeRA6BzwGvyaNrMdAgPADNIQowiEkkB76MyU0BAp8gE6cW2OMKeVwjAYkojFJUj5E84Xr5aoQrS1k4PqqaU3lApMHtbFCWV1r--Ynqnd5V8u2MPVNMA0a0a5Ms-pdYUrj56IMPgq9OUVHuSidPtvvI_R6d_syewjnz_ePs-k8lAyAh5wTxRhlXNCEcylZqiKS5ypNScIEE_5qWClJRSwhZhArvlziiEYp5wxoougIXe1yG2veO-3arCqc1GUpam06l0GUEk4oifl_KI5xQviWXv6ia9PZ2j_EqzhimGAgXl3vlLTGOavzrLFFJWyfAc62bWS-jeyrDW8v9ondstLqR35_vweTHdgUpe7_TsoWs6dd5CeGA5Hr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1474502012</pqid></control><display><type>article</type><title>Psychiatric symptoms of noradrenergic dysfunction: A pathophysiological view</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Access via Wiley Online Library</source><source>Open Access Titles of Japan</source><source>Wiley Online Library (Open Access Collection)</source><source>Alma/SFX Local Collection</source><creator>Yamamoto, Ken‐ichi ; Shinba, Toshikazu ; Yoshii, Mitsunobu</creator><creatorcontrib>Yamamoto, Ken‐ichi ; Shinba, Toshikazu ; Yoshii, Mitsunobu</creatorcontrib><description>What psychiatric symptoms are caused by central noradrenergic dysfunction? The hypothesis considered in this review is that noradrenergic dysfunction causes the abnormalities in arousal level observed in functional psychoses. In this review, the psychiatric symptoms of noradrenergic dysfunction were inferred pathophysiologically from the neuroscience literature. This inference was examined based on the literature on the biology of psychiatric disorders and psychotropics. Additionally, hypotheses were generated as to the cause of the noradrenergic dysfunction. The central noradrenaline system, like the peripheral system, mediates the alarm reaction during stress. Overactivity of the system increases the arousal level and amplifies the emotional reaction to stress, which could manifest as a cluster of symptoms, such as insomnia, anxiety, irritability, emotional instability and exaggerated fear or aggressiveness (hyperarousal symptoms). Underactivity of the system lowers the arousal level and attenuates the alarm reaction, which could result in hypersomnia and insensitivity to stress (hypoarousal symptoms). Clinical data support the hypothesis that, in functional psychoses, the noradrenergic dysfunction is in fact associated with the arousal symptoms described above. The anti‐noradrenergic action of anxiolytics and antipsychotics can explain their sedative effects on the hyperarousal symptoms of these disorders. The results of animal experiments suggest that excessive stress can be a cause of long‐term noradrenergic dysfunction.</description><identifier>ISSN: 1323-1316</identifier><identifier>EISSN: 1440-1819</identifier><identifier>DOI: 10.1111/pcn.12126</identifier><identifier>PMID: 24372896</identifier><language>eng</language><publisher>Australia: Wiley Subscription Services, Inc</publisher><subject>Adrenergic Neurons - drug effects ; Adrenergic Neurons - pathology ; Animals ; Anti-Anxiety Agents - pharmacology ; Anti-Anxiety Agents - therapeutic use ; Antipsychotic Agents - pharmacology ; Antipsychotic Agents - therapeutic use ; Anxiety ; Arousal - drug effects ; Arousal - physiology ; Behavioral Symptoms - drug therapy ; Behavioral Symptoms - physiopathology ; Humans ; hyperarousal symptoms ; Hypotheses ; locus coeruleus ; Mental Disorders - complications ; Mental Disorders - drug therapy ; Mental Disorders - physiopathology ; Mental Disorders - psychology ; noradrenaline ; pathophysiology ; stress ; Stress, Psychological - complications ; Stress, Psychological - physiopathology</subject><ispartof>Psychiatry and clinical neurosciences, 2014-01, Vol.68 (1), p.1-20</ispartof><rights>2013 The Authors. Psychiatry and Clinical Neurosciences © 2013 Japanese Society of Psychiatry and Neurology</rights><rights>2013 The Authors. Psychiatry and Clinical Neurosciences © 2013 Japanese Society of Psychiatry and Neurology.</rights><rights>Psychiatry and Clinical Neurosciences © 2014 Japanese Society of Psychiatry and Neurology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5116-662d55356a3866cc59d42ffd99285a5a7280ddc3a7c17517d6bb04349665138d3</citedby><cites>FETCH-LOGICAL-c5116-662d55356a3866cc59d42ffd99285a5a7280ddc3a7c17517d6bb04349665138d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fpcn.12126$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fpcn.12126$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,1434,27929,27930,45579,45580,46414,46838</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24372896$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamamoto, Ken‐ichi</creatorcontrib><creatorcontrib>Shinba, Toshikazu</creatorcontrib><creatorcontrib>Yoshii, Mitsunobu</creatorcontrib><title>Psychiatric symptoms of noradrenergic dysfunction: A pathophysiological view</title><title>Psychiatry and clinical neurosciences</title><addtitle>Psychiatry Clin Neurosci</addtitle><description>What psychiatric symptoms are caused by central noradrenergic dysfunction? The hypothesis considered in this review is that noradrenergic dysfunction causes the abnormalities in arousal level observed in functional psychoses. In this review, the psychiatric symptoms of noradrenergic dysfunction were inferred pathophysiologically from the neuroscience literature. This inference was examined based on the literature on the biology of psychiatric disorders and psychotropics. Additionally, hypotheses were generated as to the cause of the noradrenergic dysfunction. The central noradrenaline system, like the peripheral system, mediates the alarm reaction during stress. Overactivity of the system increases the arousal level and amplifies the emotional reaction to stress, which could manifest as a cluster of symptoms, such as insomnia, anxiety, irritability, emotional instability and exaggerated fear or aggressiveness (hyperarousal symptoms). Underactivity of the system lowers the arousal level and attenuates the alarm reaction, which could result in hypersomnia and insensitivity to stress (hypoarousal symptoms). Clinical data support the hypothesis that, in functional psychoses, the noradrenergic dysfunction is in fact associated with the arousal symptoms described above. The anti‐noradrenergic action of anxiolytics and antipsychotics can explain their sedative effects on the hyperarousal symptoms of these disorders. The results of animal experiments suggest that excessive stress can be a cause of long‐term noradrenergic dysfunction.</description><subject>Adrenergic Neurons - drug effects</subject><subject>Adrenergic Neurons - pathology</subject><subject>Animals</subject><subject>Anti-Anxiety Agents - pharmacology</subject><subject>Anti-Anxiety Agents - therapeutic use</subject><subject>Antipsychotic Agents - pharmacology</subject><subject>Antipsychotic Agents - therapeutic use</subject><subject>Anxiety</subject><subject>Arousal - drug effects</subject><subject>Arousal - physiology</subject><subject>Behavioral Symptoms - drug therapy</subject><subject>Behavioral Symptoms - physiopathology</subject><subject>Humans</subject><subject>hyperarousal symptoms</subject><subject>Hypotheses</subject><subject>locus coeruleus</subject><subject>Mental Disorders - complications</subject><subject>Mental Disorders - drug therapy</subject><subject>Mental Disorders - physiopathology</subject><subject>Mental Disorders - psychology</subject><subject>noradrenaline</subject><subject>pathophysiology</subject><subject>stress</subject><subject>Stress, Psychological - complications</subject><subject>Stress, Psychological - physiopathology</subject><issn>1323-1316</issn><issn>1440-1819</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqN0U9LwzAYBvAgipvTg19ACl700C1v0qSttzH8B0N30HPJktR1tE1NWke_vZmbHgTBXBJ4fzwkeRA6BzwGvyaNrMdAgPADNIQowiEkkB76MyU0BAp8gE6cW2OMKeVwjAYkojFJUj5E84Xr5aoQrS1k4PqqaU3lApMHtbFCWV1r--Ynqnd5V8u2MPVNMA0a0a5Ms-pdYUrj56IMPgq9OUVHuSidPtvvI_R6d_syewjnz_ePs-k8lAyAh5wTxRhlXNCEcylZqiKS5ypNScIEE_5qWClJRSwhZhArvlziiEYp5wxoougIXe1yG2veO-3arCqc1GUpam06l0GUEk4oifl_KI5xQviWXv6ia9PZ2j_EqzhimGAgXl3vlLTGOavzrLFFJWyfAc62bWS-jeyrDW8v9ondstLqR35_vweTHdgUpe7_TsoWs6dd5CeGA5Hr</recordid><startdate>201401</startdate><enddate>201401</enddate><creator>Yamamoto, Ken‐ichi</creator><creator>Shinba, Toshikazu</creator><creator>Yoshii, Mitsunobu</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201401</creationdate><title>Psychiatric symptoms of noradrenergic dysfunction: A pathophysiological view</title><author>Yamamoto, Ken‐ichi ; Shinba, Toshikazu ; Yoshii, Mitsunobu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5116-662d55356a3866cc59d42ffd99285a5a7280ddc3a7c17517d6bb04349665138d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adrenergic Neurons - drug effects</topic><topic>Adrenergic Neurons - pathology</topic><topic>Animals</topic><topic>Anti-Anxiety Agents - pharmacology</topic><topic>Anti-Anxiety Agents - therapeutic use</topic><topic>Antipsychotic Agents - pharmacology</topic><topic>Antipsychotic Agents - therapeutic use</topic><topic>Anxiety</topic><topic>Arousal - drug effects</topic><topic>Arousal - physiology</topic><topic>Behavioral Symptoms - drug therapy</topic><topic>Behavioral Symptoms - physiopathology</topic><topic>Humans</topic><topic>hyperarousal symptoms</topic><topic>Hypotheses</topic><topic>locus coeruleus</topic><topic>Mental Disorders - complications</topic><topic>Mental Disorders - drug therapy</topic><topic>Mental Disorders - physiopathology</topic><topic>Mental Disorders - psychology</topic><topic>noradrenaline</topic><topic>pathophysiology</topic><topic>stress</topic><topic>Stress, Psychological - complications</topic><topic>Stress, Psychological - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamamoto, Ken‐ichi</creatorcontrib><creatorcontrib>Shinba, Toshikazu</creatorcontrib><creatorcontrib>Yoshii, Mitsunobu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Psychiatry and clinical neurosciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamamoto, Ken‐ichi</au><au>Shinba, Toshikazu</au><au>Yoshii, Mitsunobu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Psychiatric symptoms of noradrenergic dysfunction: A pathophysiological view</atitle><jtitle>Psychiatry and clinical neurosciences</jtitle><addtitle>Psychiatry Clin Neurosci</addtitle><date>2014-01</date><risdate>2014</risdate><volume>68</volume><issue>1</issue><spage>1</spage><epage>20</epage><pages>1-20</pages><issn>1323-1316</issn><eissn>1440-1819</eissn><abstract>What psychiatric symptoms are caused by central noradrenergic dysfunction? The hypothesis considered in this review is that noradrenergic dysfunction causes the abnormalities in arousal level observed in functional psychoses. In this review, the psychiatric symptoms of noradrenergic dysfunction were inferred pathophysiologically from the neuroscience literature. This inference was examined based on the literature on the biology of psychiatric disorders and psychotropics. Additionally, hypotheses were generated as to the cause of the noradrenergic dysfunction. The central noradrenaline system, like the peripheral system, mediates the alarm reaction during stress. Overactivity of the system increases the arousal level and amplifies the emotional reaction to stress, which could manifest as a cluster of symptoms, such as insomnia, anxiety, irritability, emotional instability and exaggerated fear or aggressiveness (hyperarousal symptoms). Underactivity of the system lowers the arousal level and attenuates the alarm reaction, which could result in hypersomnia and insensitivity to stress (hypoarousal symptoms). Clinical data support the hypothesis that, in functional psychoses, the noradrenergic dysfunction is in fact associated with the arousal symptoms described above. The anti‐noradrenergic action of anxiolytics and antipsychotics can explain their sedative effects on the hyperarousal symptoms of these disorders. The results of animal experiments suggest that excessive stress can be a cause of long‐term noradrenergic dysfunction.</abstract><cop>Australia</cop><pub>Wiley Subscription Services, Inc</pub><pmid>24372896</pmid><doi>10.1111/pcn.12126</doi><tpages>20</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1323-1316 |
ispartof | Psychiatry and clinical neurosciences, 2014-01, Vol.68 (1), p.1-20 |
issn | 1323-1316 1440-1819 |
language | eng |
recordid | cdi_proquest_miscellaneous_1492623276 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Access via Wiley Online Library; Open Access Titles of Japan; Wiley Online Library (Open Access Collection); Alma/SFX Local Collection |
subjects | Adrenergic Neurons - drug effects Adrenergic Neurons - pathology Animals Anti-Anxiety Agents - pharmacology Anti-Anxiety Agents - therapeutic use Antipsychotic Agents - pharmacology Antipsychotic Agents - therapeutic use Anxiety Arousal - drug effects Arousal - physiology Behavioral Symptoms - drug therapy Behavioral Symptoms - physiopathology Humans hyperarousal symptoms Hypotheses locus coeruleus Mental Disorders - complications Mental Disorders - drug therapy Mental Disorders - physiopathology Mental Disorders - psychology noradrenaline pathophysiology stress Stress, Psychological - complications Stress, Psychological - physiopathology |
title | Psychiatric symptoms of noradrenergic dysfunction: A pathophysiological view |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T00%3A01%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Psychiatric%20symptoms%20of%20noradrenergic%20dysfunction:%20A%20pathophysiological%20view&rft.jtitle=Psychiatry%20and%20clinical%20neurosciences&rft.au=Yamamoto,%20Ken%E2%80%90ichi&rft.date=2014-01&rft.volume=68&rft.issue=1&rft.spage=1&rft.epage=20&rft.pages=1-20&rft.issn=1323-1316&rft.eissn=1440-1819&rft_id=info:doi/10.1111/pcn.12126&rft_dat=%3Cproquest_cross%3E1490708266%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1474502012&rft_id=info:pmid/24372896&rfr_iscdi=true |